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Ventricular assist devices (VADs), among which the HeartMate 3 (HM3) is the latest clinically approved 
representative, are often the therapy of choice for patients with end-stage heart failure. Despite 
advances in the prevention of pump thrombi, rates of stroke and bleeding remain high. These 
complications are attributed to the flow field within the VAD, among other factors. One of the HM3’s 
characteristic features is an artificial pulse that changes the rotor speed periodically by 4000 rpm, 
which is meant to reduce zones of recirculation and stasis. In this study, we investigated the effect of 
this speed modulation on the flow fields and stresses using high-resolution computational fluid 
dynamics. To this end, we compared Eulerian and Lagrangian features of the flow fields during constant 
pump operation, during operation with the artificial pulse feature and with the effect of the residual 
native cardiac cycle. We observed good washout in all investigated situations, which may explain the 
low incidence rates of pump thrombosis. The artificial pulse had no additional benefit on scalar 
washout performance, but it induced rapid variations in the flow velocity and its gradients. This may 
be relevant for the removal of deposits in the pump. Overall, we found that viscous stresses in the 
HM3 were lower than in other current VADs. However, the artificial pulse substantially increased 
turbulence, and thereby also total stresses, which may contribute to clinically observed issues related 
to hemocompatibility.  
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The HeartMate 3 (HM3, Abbott, St. Paul, MN, USA) is the latest clinical ventricular assist device (VAD) 
designed for long-term support of patients with advanced heart failure. It is characterized by a 
magnetic levitation system, textured blood-contacting surfaces, wide flow gaps and an artificial pulse 
[1]. Together, these features shall enhance the hemocompatibility of the pump and reduce thrombotic 
and hemorrhagic adverse events. Clinical results so far suggest that the HM3 decreases incidence rates 
of pump thrombosis and stroke compared to the HeartMate 2 (Abbott), while the rates of disabling 
stroke are  similar [2]. Bleeding rates are comparable to other VADs [2,3], even though the HM3 
appears to preserve high molecular weight von Willebrand factor (VWF) multimers better than other 
clinically used VADs [4].  
Hemocompatibility is linked to the blood flow within the VAD. This includes regions of stagnation and 
recirculation that may promote thrombus formation [5], as well as high shear areas that may activate 
platelets [6] and reduce VWF functionality [7]. It has been hypothesized that the HM3’s artificial pulse 
improves pump washout [1] and thereby inhibits pump thrombus formation. However, this hypothesis 
has not been tested so far. Further, while rotary blood pumps typically operate at a constant speed, 
maintaining some pulsatility has been hypothesized to have positive effects on the vasculature [8]. 
Evidence on the beneficial effect of periodic speed changes has been provided by comparative studies 
in patients with an HVAD (Medtronic, Minneapolis, MN, USA), which features an optional periodic 
speed modulation. Patients with the modulation enabled had significantly fewer rates of stroke, sepsis 
and right heart failure than those without, while overall survival and gastrointestinal bleeding rates 
were not affected [9].  
The HM3’s artificial pulse comprises a decrease of the pump speed by 2000 rpm, followed by an 
increase by 4000 rpm, before operation at nominal speed is resumed. This pulse lasts 350 ms and is 
repeated every 2 seconds. While the flow inside the HM3 has been investigated under steady 
conditions [1], the effects of the rapid change in rotor speed on the flow and corresponding stress 
fields have not. Given the severity of the modulation of pump operation, we view it as imperative to 
understand its influence on blood flow and to consider effects on blood components along with 
potential downstream consequences.  
To contribute to this understanding, we utilized computational fluid dynamics (CFD) and investigated 
the haemodynamic characteristics of the artificial pulse in absence of any remaining cardiac function, 
and of cardiac pulsatility without artificial pulse, comparing both to a baseline with neither native nor 
artificial pulsatility. Our CFD framework includes high-resolution dynamic flow simulations in the VAD 
and a lumped parameter representation of the cardiovascular system including the pump. We have 
analyzed the computed data with respect to Eulerian and Lagrangian characteristics linked to blood 
damage and thrombosis potential, and juxtaposed the results to clinical findings. 
 
Methods 
We simulated three different scenarios: The first one considers a remaining cardiac function and a 
HM3 operating without the artificial pulse feature with constant speed for a full cardiac cycle 
(hereinafter referred to as “cardiac cycle”). The second one considers no native heart function, but 
includes the HM3 artificial pulse (“artificial pulse”). The final one represents the baseline case with 
constant HM3 speed and no native heart function (“baseline”). We set pump speeds to maintain a 
mean cardiac output of 5 L/min [10] in all three scenarios. Boundary conditions (BCs) for the flow 
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computations in the VAD were obtained from a lumped parameter representation of the entire 
cardiovascular system, including the pump.  
Geometry 
An explanted HM3 pump was scanned using an X-ray micro computed tomography system 
(MicroDETECT, Empa, Zurich, Switzerland) as in [11]. The resulting pixel size was 30 µm. The obtained 
images were segmented using Mimics (Materialise, Leuven, Belgium) and reconstructed in Solidworks 
(Dassault Systèmes, Waltham MA, USA). The identified top and bottom gaps between rotor and 
housing are 1mm and 1.75mm, respectively.  
Computational fluid dynamic simulations  
CFD simulations were carried out using StarCCM+ (Siemens, Munich, Germany). Polyhedral grids were 
generated for all parts of the domain except inlet and outlet cannulas, including an eight-element 
boundary layer along the walls in the rotating part and a ten-element boundary layer in the volute. 
Local mesh refinement was performed where needed. A 7cm extension was added to the outlet 
cannula to avoid spurious influence of the boundary conditions on the domain of interest. Inlet cannula 
and outlet cannula plus graft extension were discretized using a directed mesh. The final grid contained 
9.95 million cells. 
The three-dimensional unsteady Reynolds-averaged Navier-Stokes equations were solved using 
implicit second order temporal and spatial discretization, a segregated flow approach and k-ω-SST 
turbulence modeling. Inlet turbulent boundary conditions were prescribed based on relationships for 
fully developed turbulent pipe flow, namely turbulent intensity = 0.16∙Re1/8 = 0.06 and turbulent length 
scale = 0.07∙D = 1.33 mm, with D being the diameter of the inlet cannula. Blood was modelled as a 
Newtonian fluid with a viscosity of 3.5 mPa∙s and a density of 1050 kg/m3. This simplification was 
considered acceptable, as the non-Newtonian properties of blood, such as shear-thinning, become 
negligible at high shear rates (> 100 s-1) [12] such as those typically found in VADs. The rotation of the 
impeller was implemented as a rigid body motion. Pressure boundary conditions were prescribed at 
the inlet and outlet. For the cardiac cycle and artificial pulse simulations, the time-dependent pressure 
BCs were obtained from the corresponding lumped-parameter simulations. 
All simulations were carried out with a convergence criterion of 10-5 for the residual errors and a time 
step corresponding to 2° of rotation. For the artificial pulse, the time step was kept constant at the 
smaller value during the ramping time, corresponding to 2° at the higher speed. Grid and time step 
independence were confirmed for pressure, velocity, and shear stresses as reported in the supporting 
information. 
Lumped parameter model  
Pressure BCs were obtained from a lumped parameter model of the entire circulation, including a 
mathematical representation of the dynamic response of the HM3. A numerical model similar to 
previously reported ones [13–16] was employed to simulate the cardiovascular system. Arterial and 
venous vasculatures were modeled as 3- and 2-element Windkessel models [17], respectively. The 
heart was modeled as having a time-varying elastance with nonlinear end-diastolic/end-systolic 
pressure-volume relationships and unidirectional valves as suggested in Colacino et al. [13]. End-
diastolic pressure-volume relationship and elastance were adapted based on [10] and [18] to mimic 
the cardiac function of a typical LVAD patient. Cardiovascular parameters were adapted to mimic the 
ones of an average LVAD patient [10] resulting in an end-diastolic left ventricular volume of 345 mL 
and an ejection fraction of 10.3 % pre-implantation. The mathematical representation of the HM3 was 
derived from in vitro experiments similar to [19,20]. The in vitro experiments were conducted on the 
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mock loop setup described in [21] using a glycerol-water mixture with a viscosity of 3.0 ± 0.1 mPa·s, 
corresponding to a hematocrit of 31 %. A 15 cm long outlet graft, which is within the range of graft 
lengths found in patients [22], was included as hydraulic resistance and inertance between the pump 
outlet and aorta. That graft was subdivided into two compartments, respectively accounting for the 
first 7 cm and subsequent 8 cm of the graft, allowing for the extraction of the pressure boundary 
conditions 7 cm away from the pump corresponding to the outlet extension included in the CFD 
simulations. 
Simulation “baseline”  
In the baseline case, we investigated the flow in the HM3 at a constant speed and no influence of the 
native circulation. The pump was operated at 5650 rpm and 80 mmHg. For assessment of the washout 
performance, CFD calculations were carried out for 40 full rotations.  
Simulation “cardiac cycle”  
In the cardiac cycle simulation, the HM3 was run at a constant speed of 5250 rpm and the effect of 
physiologic pressure pulsations induced by native heart function on the flow field within the VAD were 
investigated. Appropriate dynamic behavior was ensured by initialization over two full cardiac cycles, 
run with a time step of 4° to reduce computational effort. After initialization, one full cardiac cycle 
(0.658 s at 91.2 bpm [10] , corresponding to approximately 58 full rotations) was calculated with a time 
step size corresponding to 2°.  
Simulation “artificial pulse”  
In the artificial pulse simulation, the effect of the HM3 speed modulation on the flow field within the 
VAD was investigated. The system was initialized at 5650 rpm and a flow of 5 L/min, before the speed 
and pressure BCs including the speed change were prescribed for a total duration of 670 ms, 
corresponding to approximately 59 full rotations.  
Analyses 
We analyzed various Eulerian and Lagrangian features of the flow field both qualitatively and 
quantitatively. We calculated the scalar viscous shear stress, τvisc, from the viscous shear stress 
components, σij, according to [23,24]: 
 𝜏𝑣𝑖𝑠𝑐 = [ 112 ∑(𝜎𝑖𝑖 − 𝜎𝑗𝑗)2 + 12 ∑ 𝜎𝑖𝑗2 ]1/2 (1) 
 
Similarly, we calculated a scalar total shear stress, τtot, including turbulent stresses as 
 𝜏𝑡𝑜𝑡 = [ 112 ∑((𝜎𝑖𝑖 + 𝑠𝑖𝑖) − (𝜎𝑗𝑗 + 𝑠𝑗𝑗))2 + 12 ∑(𝜎𝑖𝑗 + 𝑠𝑖𝑗)2]1/2, (2) 
 
with the components of the Reynolds stress tensor sij  given by 
 𝑠𝑖𝑗 = −𝜌 ∙ 𝑢𝑖′𝑢𝑗′ =  − 23 𝜌𝑘𝛿𝑖𝑗 + 𝜇𝑡 (𝜕𝑢𝑖𝜕𝑥𝑗 + 𝜕𝑢𝑗𝜕𝑥𝑖 ), (3) 
where ρ is density, 𝑢′is the fluctuating component of the mean fluid velocity, k is turbulent kinetic 
energy, 𝛿𝑖𝑗  is the Kronecker delta, 𝜇𝑡 is turbulent viscosity and u is mean fluid velocity.  
To probe blood cell paths through the pump, we implemented Lagrangian particle tracking with passive 
advection. The tracked particles had a diameter of 5 µm and a density of 1125 kg/m3, which are 
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representative of, respectively, the dimension and density of red blood cells. At least 798 particles 
were seeded 44 mm downstream of the inlet with uniform spatial distribution at multiple instances in 
time. We confirmed that the derived metric (exposure time to stress above a specific threshold) did 
not depend on the number of tracked particles (supporting information).  
To investigate washout, we quantified advection of a passive scalar Φ:  
 
𝜌 𝜕ϕ𝜕𝑡 + 𝜌∇ ∙ (𝑢𝜙) = 𝑆𝜙(𝑡) 𝑆𝜙(𝑡) = {100 , 𝑡 = 𝑡00, 𝑡 ≠ 𝑡0  
 
(4) 




To confirm that the imposed BCs result in the desired fluid dynamic behavior, we compared the flow 
curves obtained with CFD to corresponding data obtained using the lumped parameter model (Figure 
1). Overall, the CFD and LP model data agree well (root mean square error of 6% and 10% for the 
cardiac cycle and artificial pulse, respectively). The arterial pulse pressures in the cardiac cycle and 
artificial pulse simulations are 5 mmHg and 11 mmHg, respectively.  
 
 
Figure 1: Calculated flow rates and corresponding model input in the ‘cardiac cycle’ (Panels A) and ‘artificial pulse’ scenarios 
(Panels B). Flow rates calculated using the lumped parameter (LP) and CFD models are shown in Panels 1 (dashed and solid 
lines, respectively). Pressure head and rotation rate were prescribed as model input (Panels 2 and 3). α1- α4 and β1- β6 
indicate time points selected to visualize the flow structures in subsequent figures. i1-i3 and j1-j3 indicate injection time 
points for Lagrangian particles highlighted in Figure 5.  
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Flow field (velocity & vorticity) 
To understand flow features inside the pump, we started by investigating the ‘baseline’ scenario 
(constant speed and constant BCs). Here, areas of flow detachment are observed at the pressure side 
and the trailing edges of the blades (Figure 2B, markers I & II). An area of stagnation forms centrally 
under the rotor (III). Vorticity is increased in regions of recirculation or flow detachment at the pressure 
side and trailing edges of the blade, in the gaps (IV), as well as at the tongue (V), depending on blade 
position (Figure 2D). In addition, we observe flow features similar to a wavy vortex flow in the side gap 
between rotor and housing (Figure 2C). The regions of flow detachment and wavy vortex pattern 
remain present during the entire rotation and occur at all tested quasi-steady flow situations (incl. the 
high flow/high speed plateau in the ‘artificial pulse’ scenario).  
 
Figure 2: General characteristics of the HM3 hemodynamics in the ‘baseline’ scenario.  A: Geometry features. B: Relative 
velocity. Here, ‘relative’ refers to the coordinate system: velocity with respect to the rotating coordinate system in the 
rotating part and relative to the laboratory system in the stationary part.  Areas of flow detachment are observed at the 
pressure sides (I) and the trailing edges (II) of the blades. An area of stagnation forms centrally under the rotor (III). C. Wall 
shear stress (WSS) on the rotor surface. Highest WSS occurs at the trailing edges. In the gap, a WSS pattern caused by wavy 
vortex-like flow is observed. D. Vorticity is increased in regions of recirculation or flow detachment at the pressure side 
and trailing edges of the blade, in the gap (IV), as well as at the tongue (V), depending on blade position. 
 
Next, we explored the influence of unsteady pump operation. In the ‘cardiac cycle’ scenario, some 
destabilization occurs during systole (Figure 3A). The area of low flow under the rotor shifts towards 
the outlet during high flow.  
The speed decrease of the artificial pulse severely destabilizes the flow, leading to multiple vortices 
(Figure 3B). Vortices form in the blade channels and centrally between their leading edges. Vortical 
structures are particularly present close to the rotating body and travel towards the inlet cannula 
during backflow. The subsequent speed increase leads to an overall stabilization of the flow. The final 
speed change from top speed back to nominal leads to the anticipated overall reduction of velocities, 




Figure 3: Relative velocities at selected time points α1-α4 (Panel A, ‘cardiac cycle’ scenario) and β1-β5 (Panel B, ‘artificial 




Turbulence and vortical structures 
Turbulence is suspected to influence blood damage [25]. Turbulence content is substantially higher in 
the ‘artificial pulse’ compared to the other two scenarios. Vortices build especially during deceleration 
of the rotor and low flow or backflow conditions, as highlighted in Figure 3.  
Stresses 
Since damage to blood components is caused, among other factors, by a combination of high stresses 
and exposure times [26], we assessed both Eulerian stress levels and computed heat maps visualizing 
time-dependent aspects.  
In the ‘baseline’ scenario, highest viscous stresses are observed at the trailing edges, in the side gaps 
and at the transition from top gap to the main flow path (Figure 4A). Total stresses are highest in the 
blade channels and the narrowest part of the volute, while they are slightly elevated in the volute 
towards the outlet. In the ‘cardiac cycle’ scenario, overall viscous and total stress levels within the rotor 
increase. Peak total stresses are observed at the pressure side of the blades, the top part of the blade 
trailing edges and the tongue (Figure 4B). In the ‘artificial pulse’ scenario, viscous stress levels in the 
rotor decrease during the period of low flow and increase during high rotational speed (Figure 4C). 
Total stresses in the rotor and volute rise considerably during the period of low flow, and zones of 
elevated stresses are also located towards the inlet. At the time of the increase in rotor speed, large 
parts of the rotor experience total stresses > 100 Pa. Overall levels of total stress decrease only as the 
system returns to nominal conditions. The difference in total stress levels between the three 
investigated scenarios is also visualized in Figure 4D, where the fluid volume exposed to total stresses 
> 150 Pa is displayed. 
A Lagrangian perspective allows the assessment of exposure times in addition to stress magnitudes, 
which is highlighted in Figure 5. Table 1 summarizes the fraction of particles exposed to stresses above 
thresholds of 9, 50 and 150 Pa, which have been suggested to be indicative of different types of blood 
damage [26] and are useful as comparative metrics between different operating conditions or pump 
designs [27].  
In the ‘cardiac cycle’ scenario, the fraction of particles exposed to viscous and total stresses above 50 
and 150 Pa (Table 1) as well as the corresponding exposure times (Figure 5, B2 and B3) are similar, 
highlighting the small contribution of Reynold stresses. For the artificial pulse case, total stresses are 
considerably higher than viscous ones, resulting in a shift to higher total stress values and longer 
exposure times (Figure 5, C3). This is also reflected in the increased number of particles exposed to 




Figure 4: Viscous and total stresses in the ‘baseline’ (Panel A), ‘cardiac cycle’ (Panel B) and ‘artificial pulse’ scenarios (Panel 
C) at selected time points as defined in Figure 1. Note the different scales for viscous and total stresses. D: Fraction of fluid 
volume with τtot > 150 Pa. Values for the ‘baseline’ and ‘cardiac cycle’ scenarios are 1.9∙10-5 and 1.6∙10-5, respectively, thus 
too small to be visible here. The pump flow rates, plotted with dotted lines, are included to aid with interpretation (values 




Figure 5: Lagrangian track data in the ‘baseline’ (Panels A), ‘cardiac cycle’ (Panels B) and ‘artificial pulse’  scenarios (Panels 
C). Panels 1: Particle tracks are colored according to the experienced total stress. In all cases, particles are injected on the 
same plane. I2 and j1 indicate the corresponding injection point for the Lagrangian particles. For the artificial pulse case, 
the effect of backflow is evident as the particles are advected back towards the inlet. Panels 2: Heat maps of exposure 
times and viscous stresses. The stresses are binned in intervals of 20 Pa (e.g. 100 Pa < τ < 120 Pa), and the exposure time 
of each track to levels of stress in each bin is calculated. The exposures times are then binned in a logarithmic manner (e.g. 
10-3 < t < 10-2). The sizes of the circles represent the number of entries per time and stress bin. Panels 3: Heat maps of 
exposure times and total stresses. In this figure, only the results of one set of tracks are displayed per simulation. The 
respective injection times are indicated in B1 and C1. Results for the other sets of tracks look qualitatively similar and are 
















pulse (%) 𝜏𝑡ℎ𝑟𝑒𝑠 = 9 𝑃𝑎 83 81 88 99 99 100 𝜏𝑡ℎ𝑟𝑒𝑠 = 50 𝑃𝑎 34 30 40  36 37 90  𝜏𝑡ℎ𝑟𝑒𝑠 = 150 𝑃𝑎 5 5  10 5 5 39  
Table 1: Fraction of particles (%) exposed to 𝝉 > 𝝉𝒕𝒉𝒓𝒆𝒔 in the ‘baseline’, ‘cardiac cycle’ and ‘artificial pulse’ scenarios. For 
the ‘cardiac cycle’ and the ‘artificial pulse’ scenarios, the numbers represent the arithmetic mean of the fraction of exposed 
particles across all sets of tracks. ‘Exposed particles’ refers to particles that were exposed to stresses above the threshold 
at least once. Each set of particle tracks corresponds to one injection time (as highlighted in Figure 1), and the individual 






To test washout behavior, which is presumably relevant for thrombus formation, we analyzed the 
relative content of a passive scalar. We found that scalar washout of the HM3 is generally good (95% 
washout after 26 rotations in the cardiac cycle case, Figure 6A), including also the stagnation area 
below the rotor observed during constant pump operation (Figure 2A). However, there remains a 
detachment area with poor washout downstream of the kink in the outlet graft (Figure 6B). In the 
‘artificial pulse’ scenario, backflow leads to particle movement in reverse direction towards the inlet, 
and increases the time until the passive scalar has left the domain. Washout is visualized in 
supplementary videos 7 to 9. 
 
Figure 6: Passive scalar washout. A. Relative content of the passive scalar (labeled ’Old blood scalar’) in the domain. The 
asterisks indicate the time point of 95% washout. The time scale is relative to the time point of initialization of the passive 
scalar. The pump flow rate is plotted with dotted lines to aid interpretation (values on right vertical axis). B. Visualizations 
of old blood scalar content at two selected time points (β2, β6) as defined in Figure 1.  
 
Stagnation and recirculation 
Since zones of stagnation and recirculation negatively affect hemocompatibility, we qualitatively and 
quantitatively assessed their extent. In the ‘baseline’ scenario, areas of stagnation are observed at the 
small step (labelled as “Step” in Figure 2A) at the transition site from inlet cannula to volute (Figure 
7A, I), at the end of the secondary flow path (II), centrally under the rotor (III), at the bottom of the 
rotor close to the inner edge (IV) and at the volute wall (V). In the ‘cardiac cycle’ scenario, the extent 
of low velocity zones (v < 0.2 m/s) remains relatively constant (Figure 7B-C), whereas in the ‘artificial 
pulse’ scenario, the volumes of low velocity peak to 12 times the ‘baseline’ scenario value during 




Figure 7: Regions of low velocity: volume with vrel < 0.2 m/s and distance from walls > 40 µm. A. ‘Baseline’ scenario. Blue 
areas indicate volumes of low velocity. The black arrows indicate areas of stagnation: at the small geometry step at the 
transition from inlet cannula to volute (I), at the end of the secondary flow path (II), centrally under the rotor (III), at the 
bottom of the rotor close to the inner edge (IV) and at the volute wall (V). B. Situation during systole in the ‘cardiac cycle’ 
scenario. C. Fluid fraction with low velocity plotted over time for the three investigated scenarios. The pump flow rate is 
plotted with dotted lines to aid interpretation (values on right vertical axis). D. Situation during low speed in the ‘artificial 
pulse’ scenario. E. Situation during high speed in the ‘artificial pulse’ scenario. The selected time points (α1, β2 and β4) refer 
to those defined in Figure 1. Videos of the regions of low velocity are available as supplementary videos 10 to 12.  
 
Validation 
To validate the CFD simulations, we compared the simulated hydraulic performance of the pump to 
values measured in vitro. We assessed the modelled pressure head for a specified flow for 7 operating 
conditions at 3 different speeds. Simulated pressures were in good agreement with experimental 
measurements with relative errors ranging between 0.7% and 13.6% (Figure 8).  
 




We carried out a high-resolution analysis of the flow inside the HM3 under dynamic conditions, and 
explored the fluid dynamic effects of its artificial pulse feature, a periodic modulation of the pump 
rotational speed intended to enhance pump washout as well as to partially restore arterial pulsatility 
[1]. We compared the effect of the HM3 artificial pulse on the flow field to that induced by the 
remaining cardiac function. Our high-resolution CFD simulations with dynamic boundary conditions 
allow for unprecedented insight into this VAD’s transient flow structures, such as temporal evolution 
of low velocity and high shear regions. This is of relevance for assessing washout and thrombus 
formation potential, and determining effective stress and exposure time profiles during physiological 
off-design point operation. In contrast to the current calculations, previous numerical investigations of 
axial or centrifugal VADs have employed moving reference frame approaches or large time-steps 
[28,29], precluding the continuous analysis of flow structures, or have relied on small time steps but 
used static boundary conditions [30,31]. 
Clinical experience to date suggests that while the HM3 significantly outperforms previous devices in 
terms of the occurrence of pump thrombosis, patients still suffer from similar rates of gastrointestinal 
bleeding and detrimental stroke [2]. From a fluid dynamic perspective, this shifts two phenomena into 
the spotlight: supra-physiological stresses for their potential to damage blood cellular and non-cellular 
components, as well as stagnation and recirculation regions for their role in thrombus formation and 
growth.   
Elevated stresses affect erythrocytes, platelets, leucocytes and blood proteins, thereby causing 
hemolysis, platelet activation and impairment of VWF function, respectively. Experimentally 
determined stress thresholds for hemolysis depend on exposure time, but are generally above 150 Pa 
[32]. However, recent evidence suggests that even subclinical hemolysis, which may occur below the 
above mentioned thresholds, might contribute to thrombotic adverse events [33]. Since viscous 
stresses in the HM3 are generally lower than 150 Pa throughout the investigated conditions, we expect 
negligible hemolysis, which fits clinical experience [2] and in-vitro experiments [1]. What could occur 
is subclinical hemolysis, possibly causing a procoagulant state. Shear-mediated platelet activation has 
been studied experimentally [34–36]. Applying the power-law model postulated in [34], our 
calculations indicate a platelet activation state below 1% in the HM3 for the observed viscous stresses 
and exposure times. However, platelet activation is also sensitive to stress gradients, and high-
frequency components (here: 82-94 Hz) have been shown to be major triggers for activation [36]. 
Analysis of our particle tracks revealed that they often contain frequencies in or above the high-
frequency range investigated in [36], suggesting that we may expect higher damage than predicted by 
the simple power-law model. Shear-mediated damage has further been shown to be a main driver of 
acquired von Willebrand syndrome (avWs), which is associated with the bleeding problems in VAD 
patients [37]. The exact relationship between shear exposure and bleeding has not yet been found, 
but experimental studies suggest that stress of the levels seen in the HM3 would, indeed, damage the 
VWF [7,38]. Aspects not included in experimental studies so far are damage accumulation and 
relaxation: Since blood components pass through the high shear environment inside the implanted 
device thousands of times, damage accumulation and relaxation between exposures could take place. 
It is known that the stress history should be taken into account to accurately predict potential damage 
[39]. Consequently, experimental results obtained for long, but single exposures (minutes in [36], 
hours in [7,38]) might still be translatable to the clinical setting, but it is not clear how such translation 
should be done. An additional challenge in the translation of in-silico or in-vitro data to the clinical 
situation is the hematologic state of the patients before VAD implantation. It has been shown that 
acute heart failure patients show increased levels of interleukin-6, which might contribute to the 
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prothrombotic state of these patients [40]. At the same time, some patients suffer from avWs already 
before VAD implantation, which might predispose them to bleeding events [41]. 
There is evidence that turbulent flow situations lead to higher blood trauma than laminar flows with 
comparable levels of viscous stresses [25]. We accommodated that fact by considering both viscous 
and total stress levels. Overall, viscous stresses in the HM3 are lower than in the HM2 and the HVAD 
[42] (see supporting information). Viscous stress levels are also generally lower in the investigated 
‘cardiac cycle’ scenario than in the ‘artificial pulse’ one. For example, approximately 30% of all particles 
are exposed to viscous stresses > 50 Pa in the former scenario, and approximately 40% in the latter. 
Due to the transient flow reversal, exposure times to given viscous shear stress levels are also slightly 
longer in the ‘artificial pulse’ scenario (Figure 5, B2 and C2). Yet, the most notable differences are 
observed in the total stress levels. Total stresses within the cardiac cycle remain similar to viscous 
stresses, highlighting limited turbulence levels and a small contribution of Reynold stresses. In 
contrast, in the ‘artificial pulse’ scenario, total stress levels and the respective exposure times are 
substantially higher than the viscous ones (Figure 5, C2 and C3). Approximately 37% of the seeded 
particles are exposed to total stresses > 50 Pa in the ‘cardiac cycle’ scenario, while in the ‘artificial 
pulse’ one 90% of the particles seeded during or shortly before the pulse are affected. Since the 
artificial pulse covers only 17.5% of the HM3’s runtime [1], this translates to approximately 44% of the 
particles being exposed to total stresses > 50 Pa assuming baseline conditions outside the pulse 
sequence. The biological effect of Reynold stresses on cells is still a matter of debate. While initially it 
was believed that Reynold stresses damage blood directly [43,44], it was later argued that Reynold 
stresses are inappropriate for direct assessment of mechanical load on cells and that, instead, the 
resulting viscous stresses should be estimated [32,45]. In conclusion, the strong increase in total 
stresses during the artificial pulse should certainly be kept in mind, but further research is needed to 
understand its potential implications for hemocompatibility and clinical outcome.  
Independent of the possible consequences, the artificial pulse significantly increased the modelled 
turbulence in the system. Flow reversal, which may not happen in all patients, reinforces the 
destabilization observed after initial deceleration of the flow. However, the strongest turbulent onset 
is clearly associated with the rapid speed increase by 4000 rpm following the period of very low flow. 
This is highlighted by the increased total stress levels (Figure 4), and might be important to consider 
during the design of artificial pulse features in general. Investigations of the impact of artificial pulses 
with different characteristics on clinical outcome would be of great value to that end.  
Beyond stresses, detrimental flow features include zones of flow detachment, which were observed 
at the pressure sides and trailing edges of the blades independent of blade position during all (quasi-) 
static situations assessed in this study. In the ‘cardiac cycle’ scenario, the detached zones close to the 
blades remained stable, while the zone under the rotor shifted and resolved during peak flow 
(supplementary videos 3, 4 and 11). The extent of these changes will depend on individual remaining 
cardiac function. In the ‘artificial pulse’ scenario, the low speed caused overall low velocities, but 
resolved all stagnation and recirculation zones. These zones of stagnation and recirculation are prone 
for thrombus growth and generally decrease the hydraulic efficiency of the pump, thus a design 
minimizing their extent is favorable.  
Good passive scalar washout performance was observed for all investigated scenarios. It therefore 
appears that washout is governed largely by the device geometry and pump flow rate. The time 
required for 95% washout was comparable to that found in the HVAD, which features a secondary flow 
path similar to the HM3 [46]. Notably, the implemented scalar only characterizes washout of a fully 
soluble quantity, neglecting effects like mechanical interaction with the wall or biological interaction 
between blood components. It is thus conceivable that although the artificial pulse does not increase 
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scalar washout, it may, in reality, help remove blood components from pump surfaces by inducing the 
observed drastic changes in the flow field and wall shear stress (WSS). When interpreted in this way, 
our results align well with clinical observations of very small numbers of pump thrombi in the HM3 [2].  
An important aspect in VADs is pulsation or the lack thereof in rotary blood pumps [47]. Speed 
modulations as in the HM3 or in the HVAD [9] are a way to induce pulsatility. The speed modulation 
studied herein resulted in a larger pressure pulse than the corresponding contribution of the residual 
cardiac function (11 vs 5 mmHg). However, it has to be kept in mind that the artificial pulse is not 
synchronized with the patient’s cardiac cycle. While we have shown here clearly that the artificial pulse 
has a substantial effect on the flow field, its biological and clinical implications remain to be resolved. 
The computational approach employed in this study comes with limitations. Since the geometry is 
reverse-engineered, small differences to the actual geometry cannot be excluded. Specifically, even 
small differences in the gap between rotor and housing can influence the obtained stress fields [27]. 
Here, the rotor position is assumed to be fixed at all operating points. Due to the passive magnetic 
bearing in the axial direction, the gap might change with changing operating conditions. Furthermore, 
we assumed rotor actuation to be perfect, implying that the rotor speed always equals its set speed. 
In our simulations, walls were assumed to be smooth in contrast to the partly sintered actual device. 
Sintered surfaces may lead to higher stresses than predicted here and could slightly reduce efficiency. 
Also, even though the turbulence modelling employed in this study follows best practices, it still 
remains an approximation. Detailed measurements of the turbulent structures in VADs have not been 
obtained to date. Since the artificial pulse feature is not synchronized with the heartbeat, the flow and 
pressure dynamics vary considerably depending on the relative temporal position of native and 
artificial pulse (periodicity > 66s for 91.2 bpm), which makes CFD simulations of scenarios including 
both the native heart function and the artificial pulse feature too costly. However, we have 
investigated such a combination using our LP model. We found that we can capture the characteristics 
of the pressure and flow curves of a combined case using our ‘cardiac cycle’ and ‘artificial pulse’ 
scenarios. In our CFD model, pressure curves are prescribed as BCs, and govern the occurring flow 
structures. Thus, while it is not feasible to run the full CFD of the combined native cardiac cycle and 
the artificial pulse, we expect that the flow patterns therein will not be fundamentally different to what 
we observed in the two isolated cases.  Consequently, we believe that the here presented results will 
aid in understanding clinically relevant flow patterns in the HM3 (see supporting information). It must 
also be noted that the flow fields formed during the artificial pulse feature, and especially possible flow 
reversals, depend on pump speed, pressure head and likely on individual patient physiology.  
 
Conclusion 
Our analysis of the fluid dynamics in the HM3 under dynamic physiologic conditions indicates good 
washout, which is in line with the clinical observation of very low pump thrombus occurrence rates. 
Viscous stress levels are slightly higher during the device’s artificial pulse, but overall lower than in 
other clinically used VADs. However, these stress levels are still above what is currently considered 
benign, which may be reflected in the clinically observed rates of stroke and bleeding, presumably 
caused, among other factors, by damage to platelets. In our simulations, the artificial pulse did not 
substantially affect washout, but sudden changes in WSS may aid removal of potential deposits in the 
pump. At the same time, the artificial pulse increased turbulence substantially. While the biologic 
effects of turbulence are not known in detail, the resulting elevated total stresses might contribute to 
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Video S1: Relative velocities in the “baseline” scenario (radial plane). 
Video S2: Relative velocities in the “baseline” scenario (axial plane). 
Video S3: Relative velocities in the “cardiac cycle” scenario (radial plane). 
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Video S4: Relative velocities in the “cardiac cycle” scenario (axial plane). 
Video S5: Relative velocities in the “artificial pulse” scenario (radial plane). 
Video S6: Relative velocities in the “artificial pulse” scenario (axial plane). 
Video S7: Passive scalar washout in the “baseline” scenario. 
Video S8: Passive scalar washout in the “cardiac cycle” scenario. 
Video S9: Passive scalar washout in the “artificial pulse” scenario. 
Video S10: Regions of low velocities in the “baseline” scenario. Blue iso-surfaces enclose volumes with a relative velocity 
< 0.2 m/s and distance from walls >40 μm. 
Video S11: Regions of low velocities in the “cardiac cycle” scenario. Blue iso-surfaces enclose volumes with a relative 
velocity < 0.2 m/s and distance from walls >40 μm. 
Video S12: Regions of low velocities in the “artificial pulse” scenario. Blue iso-surfaces enclose volumes with a relative 
velocity < 0.2 m/s and distance from walls >40 μm. 
